Yu Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yu Wang has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Chuan Guo
Orthopaedic Department, West China Hospital, Sichuan University, Chengdu, People's Republic of China
7 shared publications- Qingquan Kong
Department of Orthopedics, Orthopedic Research Institute, West China Hospital, Sichuan University, Chengdu, People’s Republic of China
7 shared publications Hao Wu
Orthopaedic Department, West China Hospital, Sichuan University, Chengdu, People's Republic of China
6 shared publicationsJin Yang
Orthopaedic Department, West China Hospital, Sichuan University/West China Hospital of Medicine, Sichuan University Chengdu, Sichuan, P.R. China
5 shared publicationsLifeng Zhang
Orthopaedic Department, West China Hospital, Sichuan University/West China Hospital of Medicine, Sichuan University Chengdu, Sichuan, P.R. China
5 shared publicationsYuqing Yan
Orthopaedic Department, West China Hospital, Sichuan University/West China Hospital of Medicine, Sichuan University Chengdu, Sichuan, P.R. China
5 shared publications
Latest Publications
- Open Access
- 11 January 2021
- Published by Springer Nature in Research Square
Short-term effectiveness of precise safety decompression via double percutaneous lumbar foraminoplasty and percutaneous endoscopic lumbar decompression for lateral lumbar spinal canal stenosis: a prospective cohort study
Purpose This prospective cohort study reports on a modified technique, namely precise safety decompression via double percutaneous lumbar foraminoplasty (DPLF) and percutaneous endoscopic lumbar decompression (PELD) for lateral lumbar spinal canal (LLSC) stenosis, and its short-term clinical outcomes.Methods The study analyzed 69 patients with single-level LLSC stenosis simultaneously occurring in both zones 1 and 2 (defined as retrodiscal space and upper bony lateral recess respectively by new LLSC classification) who underwent DPLF–PELD from November 2018 to April 2019. Clinical outcomes were evaluated according to preoperative, three months postoperatively, and last follow-up, via leg pain/low back pain (LBP) visual analog scale (VAS) scores, Oswestry disability index (ODI) scores, and the Macnab criteria. The postoperative MRI and CT were used to confirm the complete decompression, and flexion-extension x-rays at the last follow-up were used to observe lumbar stability.Results All patients successfully underwent DPLF–PELD, and the stenosis was completely decompressed, confirmed by postoperative MRI and CT. The mean follow-up duration was 13 months (range: 8–17 months). The mean preoperative leg pain VAS score is 7.05 ± 1.04 (range 5–9), which decreased to 1.03 ± 0.79(range: 0–3) at three months postoperatively and to 0.75 ± 0.63 (range: 0–2) by the last follow-up visit(p < 0.05). The mean preoperative ODI was 69.8 ± 9.05 (range: 52–85), which decreased to 20.3 ± 5.52 (range: 10–35) at the third month postoperatively and to 19.6 ± 5.21 (range: 10–34) by the final follow-up visit(p < 0.05). The satisfactory (excellent or good) results were 94.2%. There was one patient with aggravated symptoms, which were relieved after an open surgery. Two patients had a dural tear, and two patients suffered postoperative LBP. No recurrence or segmental instability was observed at the final follow-up.Conclusion DPLF–PELD could be a good alternative for the treatment of LLSC stenosis patients whose stenosis occurred in both zones 1 and 2.Trial registration Chinese Clinical Trial Registry (ChiCTR1800019551). Registered 18 November 2018.
- 11 January 2021
- Published by Springer Nature in Research Square
Open AccessShort-term effectiveness of precise safety decompression via double percutaneous lumbar foraminoplasty and percutaneous endoscopic lumbar decompression for lateral lumbar spinal canal stenosis: a prospective cohort study
Purpose This prospective cohort study reports on a modified technique, namely precise safety decompression via double percutaneous lumbar foraminoplasty (DPLF) and percutaneous endoscopic lumbar decompression (PELD) for lateral lumbar spinal canal (LLSC) stenosis, and its short-term clinical outcomes.Methods The study analyzed 69 patients with single-level LLSC stenosis simultaneously occurring in both zones 1 and 2 (defined as retrodiscal space and upper bony lateral recess respectively by new LLSC classification) who underwent DPLF–PELD from November 2018 to April 2019. Clinical outcomes were evaluated according to preoperative, three months postoperatively, and last follow-up, via leg pain/low back pain (LBP) visual analog scale (VAS) scores, Oswestry disability index (ODI) scores, and the Macnab criteria. The postoperative MRI and CT were used to confirm the complete decompression, and flexion-extension x-rays at the last follow-up were used to observe lumbar stability.Results All patients successfully underwent DPLF–PELD, and the stenosis was completely decompressed, confirmed by postoperative MRI and CT. The mean follow-up duration was 13 months (range: 8–17 months). The mean preoperative leg pain VAS score is 7.05 ± 1.04 (range 5–9), which decreased to 1.03 ± 0.79(range: 0–3) at three months postoperatively and to 0.75 ± 0.63 (range: 0–2) by the last follow-up visit(p < 0.05). The mean preoperative ODI was 69.8 ± 9.05 (range: 52–85), which decreased to 20.3 ± 5.52 (range: 10–35) at the third month postoperatively and to 19.6 ± 5.21 (range: 10–34) by the final follow-up visit(p < 0.05). The satisfactory (excellent or good) results were 94.2%. There was one patient with aggravated symptoms, which were relieved after an open surgery. Two patients had a dural tear, and two patients suffered postoperative LBP. No recurrence or segmental instability was observed at the final follow-up.Conclusion DPLF–PELD could be a good alternative for the treatment of LLSC stenosis patients whose stenosis occurred in both zones 1 and 2.Trial registration Chinese Clinical Trial Registry (ChiCTR1800019551). Registered 18 November 2018.
- Open Access
- 1 March 2020
- Published by AME Publishing Company in Annals of Palliative Medicine
- Vol. 9 (2) , 152-162
The impact of diabetes mellitus on drug resistance in patients with newly diagnosed tuberculosis: a systematic review and meta-analysis
Background: Tuberculosis and diabetes mellitus are both important global health problems now. Previous studies have drawn different conclusions about the impact of diabetes on drug resistance in patients with newly diagnosed tuberculosis. Methods: We conducted a systematic search in four databases: PubMed, EMBSE, Cochrane Library, and Web of Science. The relative risk (RR) was applied to assess the association of diabetes with drug resistance and the STATA version 12.0 was used for data synthesis. Results: A total of 13 studies involving 33,747 patients were included in our study. The pooled results revealed that presence of diabetes was significantly associated with isoniazid resistance (RR =1.22, 95% CI: 1.04–1.43) in patients with newly diagnosed tuberculosis. However, no significant impact of diabetes on rifampicin resistance (RR =0.67, 95% CI: 0.41–1.11) or multi-drug resistance (MDR) (RR =1.28, 95% CI: 0.93–1.75) was observed. The results of subgroup analysis were similar to the pooled results. No significant publication bias for the results of MDR was found. Conclusions: In patients with newly diagnosed tuberculosis, diabetes is associated with isoniazid resistance. However, there is no significant impact of diabetes on the rifampicin resistance or MDR. However, these findings still need to be verified in the future.
- 1 March 2020
- Published by AME Publishing Company in Annals of Palliative Medicine
- Vol. 9 (2) , 152-162
Open AccessThe impact of diabetes mellitus on drug resistance in patients with newly diagnosed tuberculosis: a systematic review and meta-analysis
Background: Tuberculosis and diabetes mellitus are both important global health problems now. Previous studies have drawn different conclusions about the impact of diabetes on drug resistance in patients with newly diagnosed tuberculosis. Methods: We conducted a systematic search in four databases: PubMed, EMBSE, Cochrane Library, and Web of Science. The relative risk (RR) was applied to assess the association of diabetes with drug resistance and the STATA version 12.0 was used for data synthesis. Results: A total of 13 studies involving 33,747 patients were included in our study. The pooled results revealed that presence of diabetes was significantly associated with isoniazid resistance (RR =1.22, 95% CI: 1.04–1.43) in patients with newly diagnosed tuberculosis. However, no significant impact of diabetes on rifampicin resistance (RR =0.67, 95% CI: 0.41–1.11) or multi-drug resistance (MDR) (RR =1.28, 95% CI: 0.93–1.75) was observed. The results of subgroup analysis were similar to the pooled results. No significant publication bias for the results of MDR was found. Conclusions: In patients with newly diagnosed tuberculosis, diabetes is associated with isoniazid resistance. However, there is no significant impact of diabetes on the rifampicin resistance or MDR. However, these findings still need to be verified in the future.
- 1 August 2019
- Published by Elsevier in World Neurosurgery
- Vol. 128, e504-e512
Transforaminal Percutaneous Endoscopic Decompression for Lower Thoracic Spinal Stenosis
- 1 August 2019
- Published by Elsevier in World Neurosurgery
- Vol. 128, e504-e512
Transforaminal Percutaneous Endoscopic Decompression for Lower Thoracic Spinal Stenosis
- 1 July 2019
- Published by Elsevier in World Neurosurgery
- Vol. 127, e449-e459
Full Endoscopic Transforaminal Decompression Surgery for Symptomatic Lumbar Spinal Stenosis in Geriatric Patients
- 1 July 2019
- Published by Elsevier in World Neurosurgery
- Vol. 127, e449-e459
Full Endoscopic Transforaminal Decompression Surgery for Symptomatic Lumbar Spinal Stenosis in Geriatric Patients
- 1 June 2019
- Published by Elsevier in World Neurosurgery
- Vol. 126, e16-e26
Full Endoscopic Key Hole Technique for Cervical Foraminal Stenosis: Is Mere Dorsal Decompression Enough?
- 1 June 2019
- Published by Elsevier in World Neurosurgery
- Vol. 126, e16-e26
Full Endoscopic Key Hole Technique for Cervical Foraminal Stenosis: Is Mere Dorsal Decompression Enough?
- 1 December 2018
- Published by Elsevier in World Neurosurgery
- Vol. 120, 511-515
Percutaneous Endoscopic Lumbar Discectomy for Highly Upmigrated Disc Herniation Through the Transforaminal Isthmus Plasty Approach
- 1 December 2018
- Published by Elsevier in World Neurosurgery
- Vol. 120, 511-515
Percutaneous Endoscopic Lumbar Discectomy for Highly Upmigrated Disc Herniation Through the Transforaminal Isthmus Plasty Approach
- 1 November 2018
- Published by Elsevier in World Neurosurgery
- Vol. 119, e276-e283
Percutaneous Endoscopic Lumbar Decompression for Lumbar Lateral Spinal Canal Stenosis: Classification of Lateral Region of Lumbar Spinal Canal and Surgical Approaches
- 1 November 2018
- Published by Elsevier in World Neurosurgery
- Vol. 119, e276-e283
Percutaneous Endoscopic Lumbar Decompression for Lumbar Lateral Spinal Canal Stenosis: Classification of Lateral Region of Lumbar Spinal Canal and Surgical Approaches